Postprandial platelet-poor plasma 5-hydroxytryptamine concentrations during diarrhea and constipation periods of alternating-type irritable bowel syndrome patients

Turkish Journal of Gastroenterology

Volumn 22, Issue 3, 2011, Pages 270-278

  Şen, Fatma ^a   Pinarbaşi, Binnur ^b   Işsever, Halim ^b   Akyüz, Filiz ^b   Mungan, Zeynel ^b   Kaymakoǧlu, Sabahattin ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

5 hydroxytryptamine; Alternating type irritable bowel syndrome; Bloating; Pain; Urgency

Indexed keywords

SEROTONIN;

ADULT; ARTICLE; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DIET RESTRICTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IRRITABLE COLON; MALE; MEASUREMENT; POSTPRANDIAL STATE; SEROTONIN BLOOD LEVEL; SYMPTOMATOLOGY; THROMBOCYTE POOR PLASMA;

ADOLESCENT; ADULT; BLOOD PLATELETS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONSTIPATION; DIARRHEA; DIETARY CARBOHYDRATES; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; SEROTONIN; STATISTICS, NONPARAMETRIC;

EID: 79961101682     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2011.0212     Document Type: Article

References (30)

1. Lembo T, Wright RA, Bagby B, et al. Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea predominant irritable bowel syndrome. Am J Gastroenterol 2001; 96: 2662-70.
2. Crowell MD. Role of serotonin in the pathophysiology of irritable bowel syndrome. Br J Pharmacol 2004; 141: 1285-93. (Pubitemid 38638817)
3. Bulbring E, Crema A. The action of 5-hydroxytryptamine, 5-hydroxytryptophan and reserpine on intestinal peristalsis in anaesthetized guinea-pigs. J Physiol 1959; 146: 29-53.
4. Erspamer V, Testini A. Observations on the release and turnover rate of 5-hydroxytryptamine in the gastrointestinal tract. J Pharm Pharmacol 1959; 11: 618-23.
5. Da Prada M, Tranzer JP, Pletscher A. Storage of 5-hydroxytryptamine in human blood platelets. Experimentia 1972; 28: 1328-9.
6. Tyce GM. Biochemistry of serotonin. In: Van Houtte PM, ed. Serotonin and the cardiovascular system. New York, USA: Raven, 1985; 1-14.
7. Blum I, Vered Y, Graff E, et al. The influence of meal composition on plasma serotonin and norepinephrine concentrations. Metabolism 1992; 41: 137-40.
8. Bearcroft CP, Perrett D, Farthing MJG. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut 1998; 42: 42-6. (Pubitemid 28228386)
9. Houghton LA, Atkinson W, Whitaker RP, et al. Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut 2003; 52: 663-70. (Pubitemid 36528867)
10. Dunlop SP, Coleman NS, Blackshaw E. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol 2005; 3(4): 349-57. (Pubitemid 40488343)
11. Drossman DA, Camileri M, Mayer E, et al. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123: 2108-31. (Pubitemid 35408332)
12. Veldhuyzen van Zanten S, Talley N, Bytzer P, et al. Design of treatment trials for functional gastrointestinal disorders. Gut 1999; 45: 69-77.
13. Hungin AP, Whorwell PJ, Tack J, et al. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther 2003; 17: 643-50. (Pubitemid 36418887)
14. Guilera M, Balboa A, Mearin F. Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review. Am J Gastroenterol 2005; 100: 1174-84. (Pubitemid 40769059)
15. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999; 45: 1143-47.
16. Chen JJ, Li Z, Pan H, et al. Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: abnormal intestinal motility and the expression of cation transporters. J Neurosci 2001; 21: 6348-61. (Pubitemid 32737766)
17. Atkinson W, Lockhart S, Whorwell PJ, et al. Altered 5-hydroxytryptamine signaling in patients with constipation-and diarrhea-predominant irritable bowel syndrome. Gastroenterology 2006; 130: 34-43. (Pubitemid 43049833)
18. Fuller RW, Wong DT. Serotonin uptake and serotonin uptake inhibition. Ann N Y Acad Sci 1990; 600: 68-78.
19. AIversen L. Neurotransmitter transporters: fruitful targets for CNS drug discovery. Mol Psychiatry 2000; 5: 357-62.
20. Chial HJ, Camilleri M, Burton D, et al. Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. Am J Physiol Gastrointest Liver Physiol 2003; 284: 130-7.
21. Leroi AM, Lalaude O, Antonietti M, et al. Prolonged stationary colonic motility recording in seven patients with severe constipation secondary to antidepressants. Neurogastroenterol Motil 2000; 12: 149-54. (Pubitemid 30182075)
22. Chey WY, Jin HO, Lee MH, et al. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am J Gastroenterol 2001; 96: 1499-506. (Pubitemid 32455081)
23. Bassotti G, Chistolini F, Marinozzi G, et al. Abnormal colonic propagated activity in patients with slow transit constipation and constipation- predominant irritable bowel syndrome. Digestion 2003; 68: 178-83. (Pubitemid 38250506)
24. Bazzocchi G, Ellis J, Villanueva-Meyer J, et al. Postprandial colonic transit and motor activity in chronic constipation. Gastroenterology 1990; 98: 686-93. (Pubitemid 20069705)
25. Quigley EMM. Disturbances in small bowel motility. In: Houghton LA, Whorwell PJ, eds. Irritable bowel syndrome. Baillieres clinical gastroenterelogy. London, UK: Baillieres Tindall, 1999; 385-95. (Pubitemid 29537351)
26. Spiller RC. Disturbances in large bowel motility. In: Houghton LA, Whorwell PJ, eds. Irritable bowel syndrome. Baillieres clinical gastroenterelogy. London, UK: Baillieres Tindall, 1999; 397-413. (Pubitemid 29537352)
27. Kuiken SD, Tytgat GN, Boeckxstaens GE. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study. Clin Gastroenterol Hepatol 2003; 1: 219-28. (Pubitemid 37248073)
28. Posserud I, Agerforz P, Ekman R, et al. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut 2004; 53: 1102-8. (Pubitemid 38961962)
29. Anderson GM, Feibel FC, Cohen DJ. Determination of serotonin in whole blood, platelet-rich plasma, platelet-poor plasma and plasma ultrafiltrate. Life Sci 1987; 40: 1063-70. (Pubitemid 17025624)
30. Bethea CL, Pecins-Thompson M, Schutzer WE, et al. Ovarian steroids and serotonin neural function. Mol Neurobiol 1998; 18: 87-123. (Pubitemid 29083005)